BioPharma made most significant impact on these cancer typesBreast HER2 CDK46Prostate ADTZytigaXtandiMyeloma PIIMiDsCD38Kidney VEGF mTOR IONHL CD20CML GleevecMelanoma BRAFMEK IOStill much work to be done in GIlungbrai

BioPharma made most significant impact on these cancer types: Breast - HER2, CDK4/6 Prostate - ADT/Zytiga/Xtandi Myeloma - PI/IMiDs/CD38 Kidney - VEGF, mTOR, I/O NHL - CD20 CML - Gleevec Melanoma - BRAF/MEK, I/O Still much work to be done in GI/lung/brai

08:50 EST 9 Jan 2019 | Andy Biotech

BioPharma made most significant impact on these cancer types: Breast - HER2, CDK4/6 Prostate - ADT/Zytiga/Xtandi Myeloma - PI/IMiDs/CD38 Kidney - VEGF, mTOR, I/O NHL - CD20 CML - Gleevec Melanoma - BRAF/MEK, I/O Still much work to be done in GI/lung/brain https://twitter.com/AndyBiotech/status/1082994155465392130 …

More From BioPortfolio on "BioPharma made most significant impact on these cancer types: Breast - HER2, CDK4/6 Prostate - ADT/Zytiga/Xtandi Myeloma - PI/IMiDs/CD38 Kidney - VEGF, mTOR, I/O NHL - CD20 CML - Gleevec Melanoma - BRAF/MEK, I/O Still much work to be done in GI/lung/brai"